Start for free
Start for free
MC

Merck Capital Ventures

North America, New Jersey, United States, Woodcliff Lake

Description

Merck Capital Ventures invests in companies in various stages of development from the first round of institutional funding to later stage

Investor Profile

Merck Capital Ventures has made 15 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Series B (20%)
  • Series A (13%)
  • Series E (13%)
  • Series D (13%)
  • Series C (13%)
  • Series Unknown (13%)
  • Seed (7%)
  • Series F (7%)

Country Focus

  • United States (87%)
  • United Kingdom (7%)
  • Canada (7%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Clinical Trials
  • Data Integration
  • Web Browsers
  • Pharmaceutical
  • Genetics
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Merck Capital Ventures frequently co-invest with?

KV
Kestrel Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Lundbeckfonden Ventures
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
Atlas Venture
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
SR One
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
GlaxoSmithKline
GlaxoSmithKline
Europe, England, United Kingdom, London
Co-Investments: 1
Rho Ventures
Rho Ventures
North America, New York, United States, New York
Co-Investments: 2
Solstice Capital
Solstice Capital
North America, Massachusetts, United States, Salem
Co-Investments: 3
Valley Ventures
Valley Ventures
North America, Arizona, United States, Phoenix
Co-Investments: 3
Piper Jaffray
Piper Jaffray
North America, Minnesota, United States, Minneapolis
Co-Investments: 2
HH
H&Q Healthcare Investors
North America, Massachusetts, United States, Boston
Co-Investments: 2

What are some of recent deals done by Merck Capital Ventures?

She's Well

San Francisco, California, United States

She’s Well provides subscription plans to help women and couples to preserve their fertility and have children when they’re ready.

AppsConsultingFertilityHealth CareMen'sPersonal FinanceSubscription ServiceWellnessWomen's
SeedOct 25, 2019
Amount Raised: $2,100,000
Artios Pharma

Cambridge, Cambridgeshire, United Kingdom

Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.

BiopharmaBiotechnologyMedical Device
Series BAug 10, 2018
Amount Raised: $83,005,038
Spero Therapeutics

Cambridge, Massachusetts, United States

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

BiotechnologyMedical DeviceTherapeutics
Series AJun 8, 2015
Amount Raised: $30,000,000
mihealth

Toronto, Ontario, Canada

Mihealth provides personalized web portal for patients to access their data and secure application on the patient's smart phone.

Health CareInformation TechnologySecuritySoftware
Series UnknownJan 16, 2012
HTG Molecular Diagnostics

Tucson, Arizona, United States

HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.

BiotechnologyGeneticsHealth DiagnosticsLife ScienceMedical
Series DJun 13, 2011
Amount Raised: $16,200,000
ImpactRx

Mount Laurel, New Jersey, United States

ImpactRx operates as a promotion research organization for the pharmaceutical industry.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series EJan 11, 2010
Amount Raised: $1,200,000
HTG Molecular Diagnostics

Tucson, Arizona, United States

HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.

BiotechnologyGeneticsHealth DiagnosticsLife ScienceMedical
Series CNov 28, 2008
Amount Raised: $2,800,000
PHT Corporation

Boston, Massachusetts, United States

PHT Clinical Networks, a provider of Web-based clinical trial direct data capture and management technologies

Clinical TrialsData IntegrationWeb Browsers
Series FAug 4, 2008
Amount Raised: $1,032,000
VisEn Medical

Bedford, Massachusetts, United States

VisEn Medical, Inc. designs, develops, and commercializes fluorescence in vivo imaging technology platforms. The company’s Fluorescence

BiotechnologyHealth CareMedical
Series BApr 21, 2008
Amount Raised: $5,000,000
HTG Molecular Diagnostics

Tucson, Arizona, United States

HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.

BiotechnologyGeneticsHealth DiagnosticsLife ScienceMedical
Series COct 8, 2007
Amount Raised: $5,619,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator